
|Articles|April 2, 2017
Ovarian Cancer Drug Approval Highlights AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Circulating Tumor Cells May Guide Use of Tarlatamab in Small Cell Lung Cancer
2
Pharmacists Can Implement Test-and-Treat Services in Their Practice Settings
3
FDA Grants Priority Review to Gedatolisib for HR+, HER2-Negative Advanced Breast Cancer
4
Recapping 2025 ASHP Midyear: Expanding the Pharmacist’s Role in Patient Care, Technology, and Health System Resilience
5



















































































































































































































